| Year |
Citation |
Score |
| 2022 |
Rodriguez CM, Bechek SC, Jones GL, Nakayama L, Akiyama T, Kim G, Solow-Cordero DE, Strittmatter SM, Gitler AD. Targeting RTN4/NoGo-Receptor reduces levels of ALS protein ataxin-2. Cell Reports. 41: 111505. PMID 36288715 DOI: 10.1016/j.celrep.2022.111505 |
0.694 |
|
| 2022 |
Ma XR, Prudencio M, Koike Y, Vatsavayai SC, Kim G, Harbinski F, Briner A, Rodriguez CM, Guo C, Akiyama T, Schmidt HB, Cummings BB, Wyatt DW, Kurylo K, Miller G, et al. TDP-43 represses cryptic exon inclusion in the FTD-ALS gene UNC13A. Nature. PMID 35197626 DOI: 10.1038/s41586-022-04424-7 |
0.663 |
|
| 2020 |
Rodriguez CM, Wright SE, Kearse MG, Haenfler JM, Flores BN, Liu Y, Ifrim MF, Glineburg MR, Krans A, Jafar-Nejad P, Sutton MA, Bassell GJ, Parent JM, Rigo F, Barmada SJ, et al. A native function for RAN translation and CGG repeats in regulating fragile X protein synthesis. Nature Neuroscience. PMID 32066985 DOI: 10.1038/S41593-020-0590-1 |
0.302 |
|
| 2019 |
Rodriguez CM, Todd PK. New pathologic mechanisms in nucleotide repeat expansion disorders. Neurobiology of Disease. 104515. PMID 31229686 DOI: 10.1016/J.Nbd.2019.104515 |
0.376 |
|
| 2018 |
Haenfler JM, Skariah G, Rodriguez CM, Monteiro da Rocha A, Parent JM, Smith GD, Todd PK. Targeted Reactivation of Transcription in Fragile X Syndrome Embryonic Stem Cells. Frontiers in Molecular Neuroscience. 11: 282. PMID 30158855 DOI: 10.3389/Fnmol.2018.00282 |
0.305 |
|
| Show low-probability matches. |